Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT02812927

Evaluation of Glycemic Variability (GLAIVE)

Conditions: Critical Illness, Anesthesia

Sex: All
Ages: 18 Years – 80 Years
Healthy volunteers: No
Phase: NA
Enrollment: 172
Sponsor: University Hospital, Lille

Location: Hopital Claude Huriez - CHU de Lille Lille Nord

Summary

This study compared two methods of insulin infusion by syringe pumps to assess the impact of medical devices on the glycaemic variability in patients under IIT in ICU. The main objective of the study was to show the superiority of the infusion system which permitted to dedicate a line for the insulin administration on the "standard" installation in terms of control of glycaemic variability.

Eligibility Criteria

Inclusion Criteria: * Patients under postoperative intensive care * Treatment with insulin on bi-lumen central venous catheter over than 48 hours * Eligibility for interstitial glucose monitoring * Blood glucose control every 3 hours Exclusion Criteria: * Pregnant or breastfeeding women * Patient unwilling to participate in the study * Patients participating in another study biomedical over the same period * Patient can not understand the study and its objectives * Patient under guardianship, curatorship * Patient malnourished (BMI \ 40 kg / m²) * Patient in shock (septic or hemodynamic) * Patients refusing to sign the Medtronic consent on the storage of personal data

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT02812927). StuddyBuddy aggregates publicly available trial information.